Scaling and Root Planning in a Patient Taking Chronic Corticosteroid Therapy for Lupus Erythematosus

Payam Mirfendereski; Rogan Magee; Katherine France

doi:10.1016/j.cden.2023.05.018

Scaling and Root Planning in a Patient Taking Chronic Corticosteroid Therapy for Lupus Erythematosus

Dent Clin North Am. 2023 Oct;67(4):649-651. doi: 10.1016/j.cden.2023.05.018. Epub 2023 Jun 18.

Authors

Payam Mirfendereski¹, Rogan Magee², Katherine France³

Affiliations

¹ Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, 240 South 40th Street, Philadelphia, PA 19104, USA.
² Department of Neurology, Penn Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA.
³ Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, 240 South 40th Street, Philadelphia, PA 19104, USA. Electronic address: kfrance@upenn.edu.

PMID: 37714616
DOI: 10.1016/j.cden.2023.05.018

Abstract

The dental provider should be aware of the oral manifestations of systemic lupus erythematosus (SLE). Patients with SLE may be on chronic oral corticosteroids, which can increase the risk for periodontitis and opportunistic oral infections in addition to inducing multiple systemic adverse effects. Disease complications such as lupus nephritis and comorbid antiphospholipid antibody syndrome can further impact dental decision-making including around medications to prescribe or hemostatic measures to employ during treatment. Patients with SLE on systemic corticosteroid therapy usually do not require steroid supplementation before or after non-surgical or surgical dental treatment.

Keywords: Autoimmune disease; Chronic corticosteroids; Immunosuppression; Oral manifestations; Systemic lupus erythematosus.

Publication types

Review

MeSH terms

Drug-Related Side Effects and Adverse Reactions*
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy
Opportunistic Infections*